INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 48.6 billion | 8.6% | North America |
| by Type | by Application | by End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Gastrointestinal Therapeutics Market Overview
The global gastrointestinal therapeutics market is expected to grow at 8.6% CAGR from 2020 to 2029. It is expected to reach above USD 48.6 billion by 2029 from USD 20.4 billion in 2020.
Gastrointestinal therapeutics constitutes a specialized domain within the medical field devoted to the diagnosis and treatment of ailments impacting the gastrointestinal tract. This branch of medicine concentrates on addressing disorders affecting organs situated within the gastrointestinal system, encompassing the stomach, small intestine, large intestine, and rectum. Gastrointestinal therapeutics encompass a spectrum of interventions, including pharmaceuticals aimed at mitigating symptoms, enhancing the overall functionality of the gastrointestinal system, and ameliorating the quality of life for individuals afflicted by such conditions.
The escalation in the prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastrointestinal cancers serves as a primary driver for market expansion. Contributing factors such as poor dietary habits, sedentary lifestyles, and environmental influences exacerbate the rise in incidence rates, thereby fostering a sustained demand for efficacious treatments and supporting market growth. For instance, a publication by the National Stem Cell Foundation in 2023 revealed that nearly 4% of the global populace is affected by one or more of over 80 distinct autoimmune diseases, including prevalent conditions like type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn’s disease, psoriasis, and scleroderma.
The mounting burden of gastrointestinal ailments among the populace underscores the necessity for efficacious pharmaceuticals, thereby anticipated to fuel market expansion. For example, according to statistics released by the American Cancer Society in 2023, approximately 153,020 individuals were diagnosed with colorectal cancer (CRC), including 19,550 individuals below the age of 50. Moreover, the 2023 update by Bowel Cancer United Kingdom highlights bowel cancer as the fourth most prevalent cancer, with approximately 47,700 new cases diagnosed annually in the United Kingdom. Furthermore, as indicated by an article published in the National Library of Medicine in July 2022, gastroesophageal reflux disease (GERD), the most prevalent gastrointestinal disorder, affects 20% of individuals in Western cultures.
Gastrointestinal Therapeutics Market Segment Analysis
In terms of application, the ulcerative colitis sector is predicted to contribute significantly to the gastrointestinal therapeutics market through 2028. The chronic idiopathic inflammatory condition of the gastrointestinal system mostly affects the mucosal lining of the colon. According to current research, the incidence of gastrointestinal disorders is growing in many regions of the world as a result of greater access to health care, changed lifestyles, and higher rates of industrialization and sanitation. A number of institutes are now investigating novel and promising medicinal techniques, which are projected to drive expansion in the approaching years.
Because of the increasing need for innovative therapeutics for a variety of difficult conditions, the gastrointestinal therapeutics Market Size is predicted to rise at a respectable rate between 2022 and 2028. Motility disorders, IBD, diarrheal disorders, constipation, and iatrogenic illnesses such as visceral discomfort, surgical ileus, GERD, and other esophageal problems are examples of these. Pharmacokinetics, specific diets, opioid mechanisms of drug tolerance, and the interaction between gut microbiota and pharmacotherapy, microRNA’s, constipation, purinergic medicines, and others are emerging fields in the field of GI treatments.
Gastrointestinal Therapeutics Market Players
From large companies to small ones, many companies are actively working in the gastrointestinal therapeutics market. These key players include Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc., ALLERGAN, Takeda Pharmaceutical Company Limited, AstraZeneca, Astellas Pharma US, Inc., and Pfizer Inc and others.
Companies are mainly gastrointestinal therapeutics they are competing closely with each other. Innovation is one of the most important key strategies as it has to be for any market. However, companies in the market have also opted and successfully driven inorganic growth strategies like mergers & acquisitions, and so on.
- In February 2021, Dr Reddy’s Laboratories launched Lansoprazole delayed-release orally disintegrating tablets in the United States.
- In March 2020, Sebela Pharmaceuticals received approval from the United States Food and Drug Administration (FDA) for Pizensy (lactitol) in the treatment of chronic idiopathic constipation (CIC) in adults. Penny is an osmotic laxative that works by causing the influx of water into the small intestine leading to a laxative effect in the colon.
Who Should Buy? Or Key Stakeholders
- Suppliers
- Manufacturing Companies
- End-user companies
- Research institutes
- Hospitals
Key Takeaways:
- The global gastrointestinal therapeutics market is expected to grow at 8.6% CAGR.
- In terms of application, the ulcerative colitis sector is predicted to contribute significantly to the gastrointestinal therapeutics market
- According to current research, the incidence of gastrointestinal disorders is growing in many regions.
- Global gastrointestinal therapeutics market major share is occupied by North America.
- The gastrointestinal therapeutics market is experiencing growth driven by the rising prevalence of gastrointestinal disorders and the introduction of advanced treatment options.
Gastrointestinal Therapeutics Market Regional Analysis
The gastrointestinal therapeutics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Its major share is occupied by North America, Asia Pacific, and Europe the region. North America shares 27% of the total market.
Key Market Segments: Gastrointestinal Therapeutics Market
Gastrointestinal Therapeutics Market by Type, 2020-2029, (USD Million)
- Prescription Based Gastrointestinal Therapeutics
- Otc Gastrointestinal Therapeutics
Gastrointestinal Therapeutics Market by Application, 2020-2029, (USD Million)
- Gastroenteritis
- Gi Bleeding
- Irritable Bowel Syndrome
- Peptic Ulcer Disease (Pud)
Gastrointestinal Therapeutics Market by Dosage Forms, 2020-2029, (USD Million)
- Oral
- Injections
Gastrointestinal Therapeutics Market by End User, 2020-2029, (USD Million)
- Hospitals
- Clinics
Gastrointestinal Therapeutics Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Key Question Answered
- What are the growth opportunities related to the adoption of gastrointestinal therapeutics across major regions in the future?
- What are the new trends and advancements in the gastrointestinal therapeutics market?
- Which product categories are expected to have the highest growth rate in the gastrointestinal therapeutics market?
- Which are the key factors driving the gastrointestinal therapeutics market?
- What will the market growth rate, growth momentum, or acceleration the market carries during the forecast period?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Gastrointestinal Therapeutics Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global Gastrointestinal Therapeutics Market
- Global Gastrointestinal Therapeutics Market Outlook
- Global Gastrointestinal Therapeutics Market by Dosage Forms, (USD Million)
- Oral
- Injections
- Global Gastrointestinal Therapeutics Market by Type, (USD Million)
- Prescription Based Gastrointestinal Therapeutics
- OTC Gastrointestinal Therapeutics
- Global Gastrointestinal Therapeutics Market by Application, (USD Million)
- Gastroenteritis
- GI Bleeding
- Irritable Bowel Syndrome
- Peptic Ulcer Disease (PUD)
- Global Gastrointestinal Therapeutics Market by End User, (USD Million)
- Hospitals
- Clinics
- Global Gastrointestinal Therapeutics Market by Region, (USD Million)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- Company Profiles* (Business Overview, Company Snapshot, Dosage Forms Offered, Recent Developments)
- Abbott Laboratories
- Johnson & Johnson
- AbbVie Inc.
- Salix Pharmaceuticals
- GlaxoSmithKline Plc.
- ALLERGAN
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Astellas Pharma USInc.
*The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION (USD MILLIONS), 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION (THOUSAND UNIT), 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (BRAZILD MILLIONS), 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (BRAZILD MILLIONS), 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (BRAZILD MILLIONS), 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (BRAZILD MILLIONS), 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (INDIAD MILLIONS), 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (INDIAD MILLIONS), 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (INDIAD MILLIONS), 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (INDIAD MILLIONS), 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 111Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 112Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 113Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 114Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 115Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 116Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 117Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 118Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 119Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 120Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 121Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 122Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 123Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 124Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 125Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 126Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 127Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 128Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 129Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 130Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029
TABLE 131Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 132Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 133Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 134Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 135Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 136Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 137Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 138Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 139Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 140Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 141Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 142Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 143Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 144Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 145Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 146Â Â Â Â Â Â Â Â Â Â Â Â Â UK GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 147Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 148Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 149Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 150Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 151Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 152Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 153Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 154Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 155Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 156Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 157Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 158Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 159Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 160Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 161Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 162Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 163Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 164Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 165Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 166Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 167Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 168Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 169Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 170Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 171Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 172Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 173Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 174Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 175Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 176Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 177Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 178Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 179Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 180Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 181Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 182Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 183Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 184Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 185Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 186Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 187Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 188Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029
TABLE 189Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (UAED MILLIONS), 2020-2029
TABLE 190Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 191Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (UAED MILLIONS), 2020-2029
TABLE 192Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 193Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (UAED MILLIONS), 2020-2029
TABLE 194Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 195Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (UAED MILLIONS), 2020-2029
TABLE 196Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 197Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 198Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 199Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 200Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 201Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 202Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 203Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 204Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 205Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 206Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 207Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 208Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 209Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 210Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 211Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 212Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
TABLE 213Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029
TABLE 214Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029
TABLE 215Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 216Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029
TABLE 217Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 218Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029
TABLE 219Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029
TABLE 220Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 12Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 13            PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM, USD MILLION, 2020-2029
FIGURE 15Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE, USD MILLION, 2020-2029
FIGURE 16Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER, USD MILLION, 2020-2029
FIGURE 17Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 18Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 19Â Â Â Â Â Â Â Â Â Â Â Â GASTROINTESTINAL THERAPEUTICS MARKET BY REGION 2020
FIGURE 20Â Â Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 21Â Â Â Â Â Â Â Â Â Â Â Â ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â Â Â JOHNSON & JOHNSON: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â Â Â ABBVIE INC.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â Â Â SALIX PHARMACEUTICALS: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â Â Â GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â Â Â ALLERGAN: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â Â Â TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â Â Â ASTRAZENECA: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â Â Â ASTELLAS PHARMA USINC.: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â Â Â Â Â Â Â Â Â PFIZER AC: COMPANY SNAPSHOT
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.